Company - Corporate Actions - Earnings
X.T.L. Biopharmaceuticals Ltd. (XTLB) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 XTLB 2.25%
Can-Fite Biopharma Ltd (CANF) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.36The estimated revenue is $100000
...
September 12, 2024 CANF -8.37%
Turkcell Iletisim Hizmetleri A.S. (TKC) confirmed earnings release on September 12, 2024, After the market for the quarter ending June 30, 2024.
...
September 12, 2024 TKC -0.76%
DouYu International Holdings Ltd (DOYU) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 DOYU 2.92%
MYT Netherlands Parent BV (MYTE) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $0.07The estimated revenue is $251810000
...
September 12, 2024 DOYU 2.92%
Boqii Holding Limited (BQ) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $44260600
...
September 12, 2024 BQ -0.48%
DouYu International Holdings Ltd (DOYU) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 DOYU 2.92%
Galapagos NV (GLPG) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The annoucened EPS was $0.14The estimated revenue...
September 12, 2024 GLPG 0.30%
Innate Pharma (IPHA) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 IPHA -6.63%
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 12, 2024, Before the market for the quarter ending June 30, 2024.
...
September 12, 2024 KZIA 8.40%